↓ Skip to main content

Use of NSAIDs in treating patients with arthritis

Overview of attention for article published in Arthritis Research & Therapy, July 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)

Mentioned by

news
1 news outlet
twitter
10 tweeters
facebook
2 Facebook pages
wikipedia
4 Wikipedia pages

Citations

dimensions_citation
301 Dimensions

Readers on

mendeley
612 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Use of NSAIDs in treating patients with arthritis
Published in
Arthritis Research & Therapy, July 2013
DOI 10.1186/ar4174
Pubmed ID
Authors

Leslie J Crofford

Abstract

Patients with rheumatic diseases, including rheumatoid arthritis and osteoarthritis, almost universally describe pain and stiffness as important contributors to reduced health-related quality of life. Of the treatment options available, NSAIDs are the most widely used agents for symptomatic treatment. NSAIDs are effective anti-inflammatory and analgesic drugs by virtue of their ability to inhibit biosynthesis of prostaglandins at the level of the cyclooxygenase enzyme. However, many of the adverse effects of NSAIDs are also related to inhibition of prostaglandin production, making their use problematic in some patient populations. For the clinician, understanding the biology of prostaglandin as it relates to gastrointestinal, renal, and cardiovascular physiology and the pharmacologic properties of specific NSAIDs is key to using these drugs safely. Of particular importance is the recognition of co-morbid conditions and concomitant drugs that may increase the risk of NSAIDs in particular patients. In patients with risk factors for NSAID toxicity, using the lowest dose of a drug with a short half-life only when it is needed is likely to be the safest treatment option. For those patients whose symptoms cannot be managed with intermittent treatment, using protective strategies is essential.

Twitter Demographics

The data shown below were collected from the profiles of 10 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 612 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Portugal 1 <1%
Malaysia 1 <1%
Australia 1 <1%
India 1 <1%
Argentina 1 <1%
Spain 1 <1%
Greece 1 <1%
United States 1 <1%
Unknown 604 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 117 19%
Student > Master 94 15%
Student > Ph. D. Student 73 12%
Student > Postgraduate 53 9%
Researcher 42 7%
Other 77 13%
Unknown 156 25%
Readers by discipline Count As %
Medicine and Dentistry 116 19%
Pharmacology, Toxicology and Pharmaceutical Science 107 17%
Agricultural and Biological Sciences 57 9%
Biochemistry, Genetics and Molecular Biology 56 9%
Chemistry 23 4%
Other 75 12%
Unknown 178 29%

Attention Score in Context

This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 November 2022.
All research outputs
#1,579,432
of 22,515,079 outputs
Outputs from Arthritis Research & Therapy
#251
of 2,950 outputs
Outputs of similar age
#13,397
of 177,471 outputs
Outputs of similar age from Arthritis Research & Therapy
#2
of 2 outputs
Altmetric has tracked 22,515,079 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,950 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 177,471 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one.